Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study von Cai, Lin, Li, Linfeng, Cheng, Hao, Ding, Yangfeng, Biao, Zhenshu, Zhang, Shifa, Geng, Songmei, Liu, Quanzhong, Fang, Hong, Song, Zhiqi, Lu, Yan, Li, Shanshan, Guo, Qing, Tao, Juan, He, Li, Gu, Jun, Yang, Qinping, Han, Xiuping, Gao, Xinghua, Deng, Danqi, Li, Shenqiu, Wang, Qingyu, Zhu, Jun, Zhang, Jianzhong

Volltext